Govt Invites Fresh Applications Under Bulk Drugs PLI

To boost the production of bulk drugs, the Department of Pharmaceuticals (DoP) has invited fresh applications from entities under the production-linked incentive (PLI) scheme.

- MANU KAUSHIK

Under the fifth round of the scheme, the DoP is seeking interest from the industry on 11 product categories to promote domestic manufacturing of active pharmaceutical ingredients (APIs), key starting materials (KSMs), and drug intermediates.

The notification said that applicants or their group companies, including subsidiaries, who had applied earlier under the scheme but subsequently withdrew from the scheme or whose approval was cancelled owing to non-performance, are not eligible to apply for the same eligible products.